MedTrace Logo

Viral Hepatitis B and C Infection in Patients With Idiopathic Thrombocytopenic Purpura Treated With Triple Therapy

NCT04113915 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2019-11-01

No results posted yet for this study

Summary

Aim of the work To estimate frequency of viral HB \& C infection in ITP patients who received triple therapy in comparison with another group treated with steroids only.

To explore risk factors and routes of transmission of viral HB \& C infection in ITP patients who received triple therapy and the another group treated with steroids .

\- To assess preventive measures of viral HB\& C infection in the hematology ward To investigate the influence of viral HB \& C infection on clinical picture, response to treatment and side effects in ITP patients who received triple therapy or steroids.

Conditions

  • ITP - Immune Thrombocytopenic Purpura
  • Viral Hepatitis

Interventions

DRUG

triple therapy

Effect of treatment on immunity to obtain infection with hepatitis B\&C

DRUG

Steroids

Oral or parenteral steroid therapy for ITP

Sponsors & Collaborators

  • Safaa AA Khaled

    lead OTHER

Principal Investigators

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-30
Primary Completion
2020-11-30
Completion
2020-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04113915 on ClinicalTrials.gov